Abstract:The cytotoxicity of polyethylenimine (PEI) was a dominating obstacle to its application. Introduction of poly(ethylene glycol) (PEG) blocks to PEI is one of the strategies to alleviate the cytotoxocity of PEI. However, it is well known that the transfection efficiency of PEGylated PEI is decreased to some extent compared to the corresponding PEI. Thus, the aim of our study was to enhance the transfection efficiency of PEGylated PEI. A series of tri-block co-polymers, PEG-g-PEI-g-poly(dimethylaminoethyl L-glutamine) (PEG-g-PEI-g-PDMAEG), as novel vectors for gene therapy was synthesized and evaluated. PEG-g-PEI was first obtained by linking PEG and PEI using isophorone diisocyanate (IPDI) as coupling reagent. The anionic co-polymerization of gamma-benzyl-L-glutamate N-carboxyanhydride (BLG-NCA) using PEG-g-PEI as a macro-initiator was carried out, followed by aminolysis with 2-dimethylaminoethylamine to obtain the target water-soluble tri-block co-polymer. The structures of the polymers were confirmed by FT-IR and (1)H-NMR. The influence of the molecular weight of PEI and the length of the PDMAEG chain on the physicochemical properties and transfection activity of polymer/DNA was evaluated. All PEI derivates were revealed to compact plasmid DNA effectively to give polyplexes with suitable size (approx. 100 nm) and moderate zeta potentials (10-15 mV) at N/P ratios over 10. The PEG-g-PEI-g-PDMAEG tri-block co-polymers displayed particularly low cytotoxicity, even at high concentration, reflecting an improved safety profile compared to PEI 25k. Gene transfection efficiency of PEG-g-PEI-g-PDMAEG on HeLa in the presence and absence of serum was determined. Remarkably, the transfection activity of PEG-g-PEI (10k)-g-PDMAEG (PPP-4)/DNA polyplex formulations was nearly twofold higher than PEI 25k/DNA formulations in vitro, and the transfection efficiency was less affected by the presence of serum. These results indicated that the synthesized PEG-g-PEI-g-PDMAEG tri-block co-polymers are promising candidates as carriers for gene delivery. (C) Koninklijke Brill NV, Leiden, 2010

The use of PEGylated poly [2-(N,N-dimethylamino) ethyl methacrylate] as a mucosal DNA delivery vector and the activation of innate immunity and improvement of HIV-1-specific immune responses.

pH-Responsive PEGylated Gene Delivery System

Hyperbranched PEGmethacrylate linear pDMAEMA block copolymer as an efficient non-viral gene delivery vector

Controlled Release of PEI/DNA Complexes from PLGA Microspheres As a Potent Delivery System to Enhance Immune Response to HIV Vaccine DNA Prime/mva Boost Regime.

Enhanced Immune Response Against HIV-1 Induced by a Heterologous DNA Prime-Adenovirus Boost Vaccination Using Mannosylated Polyethyleneimine As DNA Vaccine Adjuvant

Enhanced Immunostimulatory Activity of a Cytosine-Phosphate-Guanosine Immunomodulator by the Assembly of Polymer DNA Wires and Spheres

Highly Branched Poly(β-amino esters) for Non-Viral Gene Delivery: High Transfection Efficiency and Low Toxicity Achieved by Increasing Molecular Weight.

PEG- and PDMAEG-graft-modified branched PEI as novel gene vector: synthesis, characterization and gene transfection.

Poly(ethylene Glycol)-Poly-l-glutamate Complexed with Polyethyleneimine-Polyglycine for Highly Efficient Gene Delivery in Vitro and in Vivo.

Encapsulating Polyethyleneimine-DNA Nanoplexes into PEGylated Biodegradable Microparticles Increases Transgene Expression In Vitro and Reduces Inflammatory Responses In Vivo

An acid-labile block copolymer of PDMAEMA and PEG as potential carrier for intelligent gene delivery systems.

A facile and scalable method to synthesize PEGylated PDMAEMA for gene delivery

PEG-conjugated PAMAM Dendrimers Mediate Efficient Intramuscular Gene Expression

PEGylated poly(amine-co-ester) micelles as biodegradable non-viral gene vectors with enhanced stability, reduced toxicity and higher in vivo transfection efficacy

[Pegylation of Polyamidoamine Dendrimer and the Properties for Gene Vectors].

Improvement of Cellular Uptake and Transfection Ability of Pdna Using Α-Cyclodextrin-polyamidoamine Conjugates As Gene Delivery System

Polymeric nanoengineered HBsAg DNA vaccine designed in combination with β‑glucan

Pdmaema-B-Polysulfobetaine Brushes-Modified Epsilon-Polylysine As A Serum-Resistant Vector For Highly Efficient Gene Delivery

Improvement of Gene Delivery of PDMAEMA by Incorporating a Hyperbranched Polymer Core.

Amino Acid-Linked Low Molecular Weight Polyethylenimine for Improved Gene Delivery and Biocompatibility

Molecularly Engineered Poly(ortho Ester) Microspheres for Enhanced Delivery of DNA Vaccines